Figure 1 (Myobloc 01)
Myobloc Injection, Solution
Product Images NDC 10454-712
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Myobloc (NDC 10454-712). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Solstice Neurosciences, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure 2 (Myobloc 02)
Figure 3 (Myobloc 03)
This text appears to be presenting numerical data related to a clinical trial or study. The values represent factors such as the dosage or efficacy of a treatment, and are presented as percentages. There is also a reference to a "placebo" treatment. The final line may indicate a certain timeframe within the study, possibly one week post-injection. Overall, the incomplete and fragmented nature of the text makes it difficult to fully understand the context and purpose of these numbers.*
Principal Display Panel (0.5 mL Vial Carton)
This is a medication guide for "MYOBLOC" which is an injection used for intramuscular and intraglandular use. It contains 2,500 units and has no U.S. standard of potency. The dosing units of botulinum toxins cannot be interchanged between commercial products. It comes in a single-use vial and the unused portion should be discarded. It is ready to use and no reconstitution is required. It can be diluted with 0.9% Sodium Chloride Injection. It is manufactured by Solstice Neurosciences, LLC, which is a wholly-owned subsidiary of US WorldMeds, LLC. It has a warning label and there are specific dosage guidelines included in the prescribing information.*
Principal Display Panel (1 mL Vial Carton)
This is a product label for RimabotulinumtoxinB, an injection for intramuscular and intraglandular use. Each single-dose vial contains 5,000 units of the drug and is not interchangeable with other products. The label provides information on dosage, storage instructions, and manufacturer details. The drug is manufactured by Solstice Neurosciences, LLC, a wholly-owned subsidiary of US WorldMeds, LLC. The drug is ready to use, with no reconstitution required, and can be diluted with 0.9% Sodium Chloride Injection. The label also provides the drug's dosage and warnings about the dosing units of hotulinum toxins, which are not interchangeable between commercial products.*
Principal Display Panel (2 mL Vial Carton)
This is a product description of the medication MYOBLOC, containing rimabotulinumtoxinB. It comes in a single-dose vial and is used for intramuscular and intraglandular use to manage spasms and wrinkles. The dosage information can be found in the prescribing information, and the medication should not be frozen or shaken. It can be diluted with 0.9% sodium chloride injection, and the single-use vial should be discarded after use. The product is manufactured by Solstice Neurosciences, a wholly-owned subsidiary of US WorldMeds, LLC, and has a US license number of 1718.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
